Clinical relevance of the 21-gene Recurrence Score(®) assay in treatment decisions for patients with node-positive breast cancer in the genomic era

In contemporary management of early-stage breast cancer, clinical decisions regarding adjuvant systemic therapy are increasingly made after considering both genomic assay results and clinico-pathologic features. Genomic information augments the prognostic information gleaned from clinico-pathologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamounas, Eleftherios P., Russell, Christy A., Lau, Anna, Turner, Michelle P., Albain, Kathy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102296/
https://www.ncbi.nlm.nih.gov/pubmed/30155517
http://dx.doi.org/10.1038/s41523-018-0082-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102296/
https://www.ncbi.nlm.nih.gov/pubmed/30155517
http://dx.doi.org/10.1038/s41523-018-0082-6

Ejemplares similares